Metal Ion Interactions with mAbs: Part 2. Zinc-Mediated Aggregation of IgG1 Monoclonal Antibodies
- 11 August 2021
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 38 (8) , 1387-1395
Abstract
Purpose To evaluate the physical and chemical degradation of monoclonal antibodies in the presence of Zn2+. Methods A full length IgG1 monoclonal antibody (mAb1) was formulated with various amounts of Zn2+. The resulting mixture was incubated for several weeks at room temperature and analyzed using a variety of biochemical techniques to look for various physical (e.g. aggregation) and chemical (e.g. fragmentation) degradation pathways. Results mAb1 of the IgG1 subclass undergoes aggregation in the presence of Zn2+ in a concentration dependent manner. Up to hexamers were characterized using SEC-MALS. No fragmentation was noticed in the presence of Zn2+ as opposed to that found in our previous report when IgG1 mAbs were incubated in the presence of Cu2+ ions. Site directed mutagenesis indicated the involvement of Fc histidine (His 310) in Zn2+ mediated aggregation. Conclusions A novel metal ion mediated isodesmic aggregation mechanism was found in IgG1 class of monoclonal antibodies. Histidine residues in the Fc region were determined to be the binding site and implicated in Zn2+ mediated aggregation.Keywords
This publication has 41 references indexed in Scilit:
- High zinc ion supplementation of more than 30 μM can increase monoclonal antibody production in recombinant Chinese hamster ovary DG44 cell cultureApplied Microbiology and Biotechnology, 2015
- In silico selection of therapeutic antibodies for development: Viscosity, clearance, and chemical stabilityProceedings of the National Academy of Sciences, 2014
- Biotherapeutic Formulation Factors Affecting Metal Leachables from Stainless Steel Studied by Design of ExperimentsAAPS PharmSciTech, 2012
- Characterization of the Isomerization Products of Aspartate Residues at Two Different Sites in a Monoclonal AntibodyPharmaceutical Research, 2011
- A new roadmap for biopharmaceutical drug product development: Integrating development, validation, and quality by designJournal of Pharmaceutical Sciences, 2011
- Strategies and challenges for the next generation of therapeutic antibodiesNature Reviews Immunology, 2010
- Effect of Copper Sulfate on Performance of a Serum-Free CHO Cell Culture Process and the Level of Free Thiol in the Recombinant Antibody ExpressedBiotechnology Progress, 2008
- Antibody Structure, Instability, and FormulationJournal of Pharmaceutical Sciences, 2007
- Identification of multiple sources of charge heterogeneity in a recombinant antibodyJournal of Chromatography B: Biomedical Sciences and Applications, 2001
- Isomerization of an Aspartic Acid Residue in the Complementarity-Determining Regions of a Recombinant Antibody to Human IgE: Identification and Effect on Binding AffinityBiochemistry, 1996